The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
In vivo genome editing restores haemostasis in a mouse model of haemophilia
Open accessAbstract
Editing of the human genome to correct disease-causing mutations is a promising approach for the treatment of genetic disorders. Genome editing improves on simple gene-replacement strategies by effecting in situ correction of a mutant gene, thus restoring normal gene function under the control of endogenous regulatory elements and reducing risks associated with random insertion into the genome. Gene-specific targeting has historically been limited to mouse embryonic stem cells. The development of zinc finger nucleases (ZFNs) has permitted efficient genome editing in transformed and primary cells that were previously thought to be intractable to such genetic manipulation. In vitro, ZFNs have been shown to promote efficient genome editing via homology-directed repair by inducing a site-specific double-strand break (DSB) at a target locus, but it is unclear whether ZFNs can induce DSBs and stimulate genome editing at a clinically meaningful level in vivo. Here we show that ZFNs are able to induce DSBs efficiently when delivered directly to mouse liver and that, when co-delivered with an appropriately designed gene-targeting vector, they can stimulate gene replacement through both homology-directed and homology-independent targeted gene insertion at the ZFN-specified locus. The level of gene targeting achieved was sufficient to correct the prolonged clotting times in a mouse model of haemophilia B, and remained persistent after induced liver regeneration. Thus, ZFN-driven gene correction can be achieved in vivo, raising the possibility of genome editing as a viable strategy for the treatment of genetic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the initial efficiency of repair using zinc finger nucleases was also low and was substantially improved by subsequent work to correct hemophilia in mice12.”
From Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype (2014) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Self-citationManno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Self-citationSafety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642
Self-citationTreatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin
Hanna, J. H., Wernig, M., Markoulaki, S., Sun, C., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,521
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 549
Optimizing Delivery and Expression of Designer Nucleases for Genome Engineering
Chuah, M., & VandenDriessche, T. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.166 · Cited by 5
Corrigendum: Targeted Gene Delivery: Where to Land
Pavani, G., & Amendola, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.682171 · Cited by 5
In vivo gene therapy: A strategy for mutations, degenerations, and tumors
Wang, T., Yu, M., Liu, P., Song, Z., Li, C., Yang, J., & Liu, N. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101808 · Cited by 4
CRISPR and gene editing technologies for bleeding disorders
VandenDriessche, T., Janssens, M., & Chuah, M. (2025) · Therapeutic Advances in Hematology · doi:10.1177/20406207251387402 · Cited by 4
Targeted Mitochondrial Genome Elimination
Bacman, S. R., Pereira, C. V., & Moraes, C. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_24 · Cited by 4
Gene Therapy for Inherited Liver Disease: To Add or to Edit
Chen, Y., van Til, N. P., & Bosma, P. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312514 · Cited by 4
Gene Therapy for Sickle Cell Anemia in India - Current Status and Challenges
Goel, A., Dalal, V., Dhawan, R., Maiti, S., & Chakraborty, D. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02105-9 · Cited by 4
Cancer of mice and men: old twists and new tails
van der Weyden, L., & Adams, D. J. (2013) · The Journal of Pathology · doi:10.1002/path.4184 · Cited by 4
An ode to gene edits that prevent deafness
Urnov, F. D. (2017) · Nature · doi:10.1038/d41586-017-08645-z · Cited by 4
Brunetti‐Pierri, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817344-2.00030-7 · Cited by 4
Vector Systems for Prenatal Gene Therapy: Choosing Vectors for Different Applications
Coutelle, C., & Waddington, S. N. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-873-3_3 · Cited by 4
Genome Editing with Targetable Nucleases
Pelletier, S. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_1 · Cited by 4
Genome-editing Technologies and Patent Landscape Overview
Benahmed-Miniuk, F., Kresz, M., Kanaujiya, J. K., & Southgate, C. D. (2017) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2017-0004 · Cited by 4
Auld, D., Simeonov, A. M., Lea, W., & Thomas, C. J. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0805.lr · Cited by 4
Future Approaches in Liver Disorders: Regenerative Medicine
Jinga, M., Balaban, D. V., Bontaş, E., & Tintoiu, I. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_74 · Cited by 4
The convergence of synthetic biology and metagenomics: Current advances and future perspectives
Maqbool, M., Haque, E., Thacharodi, A., Meenatchi, R., Arafath, A. Y., Fathima, S. A., Genevieve, K. K., Singh, T., Rajalakshmi, D., Nisha, K., et al. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102506 · Cited by 3
Applications of gene modification technologies in the treatment of inherited diseases
Superson, M., Szmyt, K., Wilk-Trytko, K., Krasnoborska, J., Samojedny, S., Szymańska, K., & Walczak, K. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.66.002 · Cited by 3
Hitting the Target Without Pulling the Trigger
VandenDriessche, T., & Chuah, M. (2015) · Molecular Therapy · doi:10.1038/mt.2014.230 · Cited by 3
Application of Genome Editing Technology to MicroRNA Research in Mammalians
Yu, L., Batara, J., & Lü, B. (2016) · InTech eBooks · doi:10.5772/64330 · Cited by 3
An Overview of rAAV Vector Product Development for Gene Therapy
Snyder, R. O. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-3228-3_2 · Cited by 4
Ramakrishnaiah, T. N., Ramachandregowda, S., Muktha, H., Surendra, A. S., Tanvi, Y., Srikar, K. S., & Rajashekara, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106798 · Cited by 3
In vivo Gene Correction of Cystic Fibrosis
Kormann, M. (2015) · InTech eBooks · doi:10.5772/60697 · Cited by 3
Li, G., HE, X., & Sun, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2668 · Cited by 3
Genome Editing for Neuromuscular Diseases
Ousterout, D. G., & Gersbach, C. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_4 · Cited by 4
Somatic Genome Editing for Health: Disease Treatments and Beyond
Ishii, T. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0061-5 · Cited by 3
Genome Editing Tools: Need of the Current Era
Aslam, S., Khan, S. H., Ahmed, A., & Dandekar, A. M. (2019) · American Journal of Molecular Biology · doi:10.4236/ajmb.2019.93008 · Cited by 3
Targeted Genome Engineering and Its Application in Trait Improvement of Crop Plants
Yang, X., Luo, L., Mo, B., & Liu, L. (2019) · Agricultural Sciences · doi:10.4236/as.2019.1010097 · Cited by 3
Kamimura, K., Kanefuji, T., Suda, T., Yokoo, T., Zhang, G., Aoyagi, Y., & Liu, D. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.018 · Cited by 3
Dane, A. P., Cunningham, S. C., Kok, C., Logan, G. J., & Alexander, I. E. (2015) · Gene Therapy · doi:10.1038/gt.2015.66 · Cited by 3
Nuclease‐stimulated homologous recombination at the human β‐globin gene
Vannocci, T., Kurata, H., de la Fuente, J., Roberts, I. A. G., & Porter, A. C. G. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2751 · Cited by 4
TALE nucleases as a new tool for genome editing
Glazkova, D. V., & Shipulin, G. A. (2014) · Molecular Biology · doi:10.1134/s0026893314030054 · Cited by 3
[Research advances on gene therapy for hemophilia A].
Li, X., Zhang, J., Zhang, L., Cheng, T., & Zhang, X. (2015) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2015.07.022 · Cited by 3
Adeno-Associated Vectors for Gene Delivery to the Nervous System
Mulcahy, P. J., Binny, C., Muszynski, B., Karyka, E., & Azzouz, M. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_1 · Cited by 3
Endonuclease mediated genome editing in drug discovery and development: promises and challenges
Prabhu, V., & Xu, H. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.09.007 · Cited by 3
Key to Delivery: The (Epi-)genome Editing Vector Toolbox
Just, S., & Büning, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7774-1_7 · Cited by 3
Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9Preprint
Agudelo, D., Carter, S., Velimirovic, M., Duringer, A., Levesque, S., Rivest, J.-F., Loehr, J., Mouchiroud, M., Cyr, D., Waters, P. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/321208 · Cited by 3
Self-citationRivest, J.-F., Carter, S., Goupil, C., Antérieux, P., Cyr, D., Ung, R., Soglio, D. B. D., Mac‐Way, F., Waters, P. J., Paganelli, M., et al. (2024) · Genetics · doi:10.1093/genetics/iyae139 · Cited by 3
Self-citationGene therapy and editing in the treatment of hereditary blood disorders: Medical and ethical aspects
Alburquerque, P. C., Gómez‐Tatay, L., & Aznar, J. (2021) · Clinical Ethics · doi:10.1177/14777509211057255 · Cited by 2
Zinc Finger Nuclease Editing of Hematopoietic Stem Cells as an Anti-HIV Therapy
Holt, N. G., Exline, C. M., Mulhern, O., Hofer, U., Burke, K. A., Oldenburg, J. E., & Cannon, P. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1655-9_32 · Cited by 2
Current status of hemophilia gene therapy
Kashiwakura, Y. (2024) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.35.60 · Cited by 2
Advanced therapies for hemophilia: reality or fantasy?
Liras, A. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.25 · Cited by 2
Scalable manufacturing methodologies for improving adeno-associated virus-based pharmaprojects
Xu, Z., Shi, C., & Qian, Q. (2014) · Chinese Science Bulletin · doi:10.1007/s11434-014-0197-6 · Cited by 2
Prospect and progress of gene therapy in acute intermittent porphyria
D’Avola, D., & González‐Aseguinolaza, G. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1191346 · Cited by 2
Ede, D., Farhang, N., Stover, J. D., & Bowles, R. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.09290-0 · Cited by 2
An introduction to CRISPR-Cas systems for reprogramming the genome of mammalian cells
Singh, V. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.010 · Cited by 2
Clinical implementation of genome editing for correction of human diseases
Popova, M. O., Lepik, K. V., Sergeev, V. S., Shakirova, A. I., Potter, A. Y., Muslimov, A. R., Barkhatov, I., & Afanasyev, B. V. (2017) · Cellular Therapy and Transplantation · doi:10.18620/ctt-1866-8836-2017-6-1-37-43 · Cited by 2
Gene Therapy for Liver Disease
Aravalli, R. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00060-6 · Cited by 2
Gene editing technology for improving life quality: A dream coming true?
Ramezankhani, R., Minaei, N., Haddadi, M., Torabi, S., Hesaraki, M., Mirzaei, H., Vosough, M., & Verfaillie, C. M. (2020) · Clinical Genetics · doi:10.1111/cge.13794 · Cited by 2
iGUIDE Method for CRISPR Off-Target Detection
Nobles, C. L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0822-7_6 · Cited by 2
Huntington's Disease and Other Choreas
Salman, H., Wild, E. J., & Tabrizi, S. J. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch21 · Cited by 2
Amelioration of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integrationPreprint
Chen, X., Niu, X., Liu, Y., Zheng, R., Wang, L., Yang, L., Lu, J., Yin, S., Shao, Y., Yu, W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.435908 · Cited by 2
Evolution of Transgenic Technology: From Random Transgenesis to Precise Genome Editing
Saugandhika, S., & Jain, N. (2024) · Sustainable agriculture reviews · doi:10.1007/978-3-031-54372-2_3 · Cited by 1
Gene Editing for Haemophilia—The Next Frontier
Pinotti, M., Newby, G. A., Selvaraj, S. R., & Pipe, S. W. (2026) · Haemophilia · doi:10.1111/hae.70238 · Cited by 1
Editing Cultured Human Cells: From Cell Lines to iPS Cells
Li, H. L., & Hotta, A. (2014) · Springer eBooks · doi:10.1007/978-4-431-55227-7_3 · Cited by 1
Self-citationGene targeting with nucleases: capped templates, semper fidelis?
Scharenberg, A. M. (2014) · Nature Methods · doi:10.1038/nmeth.3110 · Cited by 1
Transcription–replication collision increases recombination efficiency between plasmids
Li, J., Feng, C., Zhen, X., Jibing, C., Lv, X., Zhang, L., & DePei, L. (2013) · Plasmid · doi:10.1016/j.plasmid.2013.10.001 · Cited by 1
Maßgeschneidertes Genom — Designer-Nukleasen im Einsatz
Bednarski, C., & Cathomen, T. (2015) · BIOspektrum · doi:10.1007/s12268-015-0528-4 · Cited by 1
The Rejection Barrier to Induced Pluripotent Stem Cells
Balasubramanian, S., Kota, S. K., & Valerius, M. T. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070707 · Cited by 1
The Use and Development of TAL Effector Nucleases
Juillerat, A., Duchateau, P. N., Cathomen, T., & Mussolino, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_3 · Cited by 1
The Current State-of-the-Art in Therapeutic Genome Editing and the Future
Manesh, D. M., & Malik, P. (2016) · Gene Technology · doi:10.4172/2329-6682.1000135 · Cited by 1
A Southern Blot Protocol to Detect Chimeric Nuclease-Mediated Gene Repair
Rocca, C. J., Abdul-Razak, H. H., Holmes, M. C., Gregory, P. D., & Yáñez‐Muñoz, R. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-761-7_21 · Cited by 1
Self-citationDolan, G. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12924 · Cited by 1
Auld, D., Lea, W., Davis, M. I., & Simeonov, A. M. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2011.0905.lr · Cited by 1
Gene Therapies in the Fight against Liver Disease: A Comprehensive Review
Leff, P., Aboona, M. B., Choday, S., Ali, Q., Wijarnpreecha, K., & Alkhouri, N. (2024) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2024/v36i55413 · Cited by 1
Peek Before You Treat? Is It a Fantasy or Reality?
Ajani, J. A., Mangu, P. B., & Burstein, H. J. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000405 · Cited by 1
CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells
Zhang, J., Neises, A., Cheng, T., & Zhang, X. (2015) · SpringerBriefs in stem cells · doi:10.1007/978-94-017-7312-6_8 · Cited by 1
Molecular and Genetic Medicine
Bergmann, T., Ehrke‐Schulz, E., & Ehrhardt, A. (2014) · Cited by 1
Using Engineered Nucleases to Create HIV-Resistant Cells
Llewellyn, G. N., Exline, C. M., Holt, N. G., & Cannon, P. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_10 · Cited by 1
Ng, H. (2014) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v43n1p68 · Cited by 1
Stimulation of AAV Gene Editing via DSB Repair
Mitchell, A. M., Moser, R. J., Samulski, R. J., & Hirsch, M. L. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_8 · Cited by 1
Wang, G., Yang, L., Chai, B., Zhang, C. M., Wang, M. F., Wang, K., Chen, Y., & Li, L. (2016) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2016.05.007 · Cited by 1
Geny, S., Hosseini, E. S., Concordet, J., & Giovannangeli, C. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00400 · Cited by 1
Elimination of Mutant Mitochondrial DNA in Mitochondrial Myopathies Using Gene-Editing Enzymes
Bacman, S. R., & Moraes, C. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_34 · Cited by 1
[Establishment and verification of a mouse model of Gata4 gene H435Y mutation].
Zhang, H., Chen, M., Fang, T., Zhang, T., & Ni, W. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.10.15 · Cited by 1
The basics of molecular pathology
Nuovo, G. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820653-9.00002-x · Cited by 1
Gene Therapy in Liver Disease: Challenges and Outcomes
Premkumar, M., & Singh, V. (2022) · Springer eBooks · doi:10.1007/978-981-16-8845-4_14 · Cited by 1
Applications of CRISPR/Cas9 in agriculture, nutrition, health and disease
Satheesh, S. V., Rasmussen, M., & Matthews, J. B. (2019) · Norsk tidsskrift for ernæring · doi:10.18261/ntfe.17.2.5 · Cited by 1
Lundstrom, K. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00049-4 · Cited by 1
Future directions for gene therapy
Kaneda, Y. (2013) · doi:10.2217/ebo.12.155 · Cited by 1
Basson, M., Chmielnicki, E., Silva, K. D., Farrell, A., Levinson, R. S., López, J. C., Pola, C., & Swami, M. (2011) · Nature Medicine · doi:10.1038/nm1211-1540 · Cited by 1
Asp, P., Guha, C., Chowdhury, N. R., & Chowdhury, J. R. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch73 · Cited by 1
Amelioration of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integrationPreprint
Li, D., Chen, X., Niu, X., Liu, Y., Zheng, R., Wang, L., Yang, L., Lu, J., Yin, S., Shao, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-302699/v1 · Cited by 1
Disorders of Hemostasis and Thrombosis
Weyand, A. C., Shavit, J. A., & Ginsburg, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-812534-2.00003-5 · Cited by 1
Could targeted gene insertion of factor 9 be a potential durable treatment for Hemophilia B?
Castaman, G., & Pinotti, M. (2025) · Expert Review of Hematology · doi:10.1080/17474086.2025.2459253 · Cited by 1
Gene editing approaches of microsatellite disorders : shortening expanded repeats
Poggi, L. (2020) · theses.fr (ABES) · doi:10.70675/741f0470z28a0z4c3bz9e75ze578bdc49074 · Cited by 1
On the Search for Reliable Human Aging Models: Understanding Aging by Nuclear Reprogramming
Sancho-Martinez, I., Nivet, E., & Belmonte, J. C. I. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_11
Synthetic Biology-Based Approaches to Enhance Transgene Attributes
Chakraborty, S. (2014) · DukeSpace (Duke University)
Hemophilia Gene Therapy: An Overview
Lillicrap, D. (2014) · Wiley eBooks · doi:10.1002/9781118398258.ch40
Translating Stem Cells to the Clinic: From Modeling Disease to Cellular Products
Nivet, E., Sancho-Martinez, I., & Belmonte, J. C. I. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200018
Engineering the Human Genome: Reflections on the Beginning
Bushman, F. D. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.2524 · Cited by 1
Self-citationProspects for Prenatal Gene Therapy
Coutelle, C. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025275
Ramirez, C. L. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Li, P., Pan, Y., Li, A. S. S., Sun, A., Zhang, J., Gao, H., Sirois, P., & Li, K. (2013) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2013.31001
Cut-and-paste therapy fixes mouse haemophilia
Weaver, J. (2011) · Nature · doi:10.1038/news.2011.384
Gene Therapists Determined to Stop the Bleeding!
Sarkar, D., Perrin, G. Q., Zolotukhin, S., Srivastava, A., & Herzog, R. W. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-015
Gene Therapy using Zinc Finger Nucleases for the Treatment of Acute T-Cell Leukemia
Bartz, K., & Gallicchio, V. S. (2014)
Progress and challenges in gene therapy for Crigler–Najjar syndrome
Aronson, S. J., Beuers, U. H., & Bosma, P. J. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1100991
Genetic Engineering Cures Hemophilia B in Mice
Komaroff, A. L. (2011) · Journal watch · doi:10.1056/jw201108090000006
Zinc-Finger Nucleases: the past and future of in vivo genome editing
VanderWeide, K. (2012) · Alfred University Research and Archives (AURA) (Alfred University)
Progress of genome editing approaches towards gene therapy
Hai, J., & Zhu, H. (2015) · Shengming kexue
Metadata
- Authors
- Li, H., Haurigot, V., Doyon, Y., Li, T., Wong, S. Y., Bhagwat, A. S., Malani, N., Anguela, X. M., Sharma, R., Ivanciu, L., Murphy, S. L., Finn, J. D., Khazi, F. R., Zhou, S., Paschon, D. E., Rebar, E. J., Bushman, F. D., Gregory, P. D., Holmes, M. C., & High, K. A.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Sangamo BioSciences (United States) (US)
- University of Pennsylvania (US)
- Corresponding author
- Holmes, Michael C.
- High, Katherine A.
- ORCID
- Venue
- Nature
- Published
- 2011-06-26
- Volume
- 475
- Issue
- 7355
- Pages
- 217-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3152293
- OpenAlex
- W2038866304
- Cited by
- 548
- References
- 29
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 22 · 2021: 19 · 2020: 34 · 2019: 33 · 2018: 48 · 2017: 54 · 2016: 66 · 2015: 62 · 2014: 66 · 2013: 44 · 2012: 40
- FWCI
- 35.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (P01HL064190, T32HL007150)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- zinc finger nucleases, genome editing, hemophilia B, in vivo gene targeting, DNA double-strand breaks, homology-directed repair, gene replacement, liver regeneration, genetic disease treatment
- MeSH terms
- Animals, Base Sequence, Hemophilia B, Disease Models, Animal, DNA Repair, Endonucleases, Exons, Factor IX, Genetic Vectors, Hemostasis, Humans, Introns, Liver, Liver Regeneration, Mice, Inbred C57BL, Mutation, Phenotype, Genetic Therapy, Zinc Fingers, Genome, Sequence Homology, Gene Targeting, Cell Line, Tumor, Mice, DNA Breaks, Double-Stranded, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
